The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Sat., Aug. 17, 11:19 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #20. Forest Laboratories Furiex Pharmaceuticals

Acquirer: Forest Laboratories (FRX)
Acquiree: Furiex Pharmaceuticals
Details: Forest Laboratories, Inc. (NYSE:FRX) will hold a conference call with investors at 9:30 AM EST today to discuss the details of this morning's announcement that Forest has entered into a definitive agreement to acquire Furiex, a drug development collaboration company. Note that the call time has been changed from 8:30 AM EST.

Forest Laboratories is a pharmaceutical company that develops, manufactures, and sells branded forms of drug products, most of which require a physician's prescription. Co.'s primary products in the U.S. are marketed directly, or detailed, to physicians by its salesforces. Co. also focuses on the development and introduction of new products, including products developed in collaboration with its licensing partners. Co.'s products include those developed by Co., those developed in conjunction with its partners and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems.

Open the FRX Page at The Online Investor »

Company Name: 
Forest Laboratories, Inc.
Stock buyback: 
FRX buyback
Website: 
www.frx.com
Sector: 
Drugs & Pharmaceuticals
 

Open the FRX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Hold (2.47 out of 4)
96th percentile
(ranked higher than approx. 96% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 20 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.